Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-31 @ 12:47 AM
Study NCT ID:
NCT04772534
Status:
COMPLETED
Last Update Posted:
2025-05-30
First Post:
2021-02-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-06
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-23
First Submit QC Date:
None
Study First Post Date:
2021-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-25
Results First Submit QC Date:
None
Results First Post Date:
2025-05-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-29
Last Update Post Date:
2025-05-30
Last Update Post Date Type:
ACTUAL